News
Patient safety vs. public health: The ethylene oxide dilemma
While the FDA says it “shares concerns about the release of ethylene oxide at unsafe levels into the environment,” the agency cautions that moving...
News
Alcohol consumption may not influence breast cancer prognosis, study
The findings could help in developing specific guidelines related to the prevention of breast cancer recurrence and death in survivors.
News
FDA approves elranatamab for multiple myeloma
Elranatamab previously received Breakthrough Therapy Designation for relapsed or refractory multiple myeloma.
News
FDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancer
This new agent "brings an important treatment option to patients with prostate cancer as they consider their road ahead."
News
FDA OKs talquetamab, a first-in-class myeloma tx
Accelerated approval has been granted by the FDA to talquetamab-tgvs, a bispecific antibody, for patients with myeloma who have undergone at least...
News
AI-supported breast screens may reduce radiologist workload
The potential for overdiagnosis or overdetection of indolent lesions in the intervention group should “prompt caution in the interpretation of...
News
Oncologists challenge ‘burdensome’ MOC requirements
“It’s a pain-in-the-ass module that you sit at home and Google – it’s not really any sort of assessment,” nor does it help protect the public.
News
New global initiative aims to reform cancer trials and care
“One concern is that over the last 10 years or so, most of our new treatments have had very, very small benefits and we think the bar has dropped...
News
WHO declares aspartame as possible carcinogen
“In short the evidence that aspartame causes primary liver cancer, or any other cancer in humans, is very weak.”
News
Higher alcohol consumption linked to early-onset CRC
Compared with light drinking, moderate and heavy drinking were associated with a significantly elevated risk of early-onset CRC.
News
FDA approves talazoparib for metastatic prostate cancer
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
News
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
News
FDA approves new indication for avapritinib
Purported “first and only approved medicine” to treat adults with indolent systemic mastocytosis has been greenlit by the FDA.
News
Focus of new ASH VTE guidelines: Thrombophilia testing
New guidelines recommend testing for thrombophilia in patients with VTE provoked by a nonsurgical major transient risk factor or associated with...
News
SCC from breast implants: Negligible risk, study finds
Regarding SCC, “whether the observed elevated risk is associated with the implants is difficult to interpret because it is based on only one case...